Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system

被引：3

作者：

Gabuzda, Dana ^{[1
]}

McArthur, Justin C. ^{[2
]}

Letendre, Scott L. ^{[3
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[3] Univ Calif San Diego, San Diego, CA 92103 USA

来源：

AIDS | 2020年 / 34卷 / 13期

关键词：

ATAZANAVIR/RITONAVIR PLUS LAMIVUDINE; FLUID VIRAL ESCAPE; CEREBROSPINAL-FLUID; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; RNA; PERSISTENCE; PREVALENCE;

D O I：

10.1097/QAD.0000000000002665

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1975 / 1977

页数：3

共 30 条

[1] Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy [J].

Anderson, Albert M. ;

Munoz-Moreno, Jose A. ;

McClernon, Daniel R. ;

Ellis, Ronald J. ;

Cookson, Debra ;

Clifford, David B. ;

Collier, Ann C. ;

Gelman, Benjamin B. ;

Marra, Christina M. ;

McArthur, Justin C. ;

McCutchan, J. Allen ;

Morgello, Susan ;

Sacktor, Ned ;

Simpson, David M. ;

Franklin, Donald R. ;

Heaton, Robert K. ;

Grant, Igor ;

Letendre, Scott L. .

JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (01) :105-113

[2] Low atazanavir concentrations in cerebrospinal fluid [J].

Best, Brookie M. ;

Letendre, Scott L. ;

Brigid, Eileen ;

Clifford, David B. ;

Collier, Ann C. ;

Gelman, Benjamin B. ;

McArthur, Justin C. ;

McCutchan, J. Allen ;

Simpson, David M. ;

Ellis, Ronald ;

Capparelli, Edmund V. ;

Grant, Igor .

AIDS, 2009, 23 (01) :83-87

[3] The impact of HIV central nervous system persistence on pathogenesis [J].

Brew, Bruce J. ;

Barnes, Stephanie L. .

AIDS, 2019, 33 :S113-S121

[4] Two-drug regimens with dolutegravir plus rilpivirine or lamivudine in HIV-1 treatment-naive, virologically-suppressed patients: Latest evidence from the literature on their efficacy and safety [J].

Cento, Valeria ;

Perno, Carlo Federico .

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 20 :228-237

[5] Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study [J].

Eden, Arvid ;

Nilsson, Staffan ;

Hagberg, Lars ;

Fuchs, Dietmar ;

Zetterberg, Henrik ;

Svennerholm, Bo ;

Gisslen, Magnus .

JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (12) :1822-1825

[6] Treatment of Central Nervous System Manifestations of HIV in the Current Era [J].

Handoko, Ryan ;

Spudich, Serena .

SEMINARS IN NEUROLOGY, 2019, 39 (03) :391-398

[7]

Joseph J, 2016, J VIRUS ERAD, V2, P243

[8] Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells [J].

Joseph, Sarah B. ;

Kincer, Laura P. ;

Bowman, Natalie M. ;

Evans, Chris ;

Vinikoor, Michael J. ;

Lippincott, Christopher K. ;

Gisslen, Magnus ;

Spudich, Serena ;

Menezes, Prema ;

Robertson, Kevin ;

Arching, Nancie ;

Kashuba, Angela ;

Eron, Joseph J. ;

Price, Richard W. ;

Swanstrom, Ronald .

CLINICAL INFECTIOUS DISEASES, 2019, 69 (08) :1345-1352

[9] Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy [J].

Kirtane, Ameya R. ;

Abouzid, Omar ;

Minahan, Daniel ;

Bensel, Taylor ;

Hill, Alison L. ;

Selinger, Christian ;

Bershteyn, Anna ;

Craig, Morgan ;

Mo, Shirley S. ;

Mazdiyasni, Hormoz ;

Cleveland, Cody ;

Rogner, Jaimie ;

Lee, Young-Ah Lucy ;

Booth, Lucas ;

Javid, Farhad ;

Wu, Sarah J. ;

Grant, Tyler ;

Bellinger, Andrew M. ;

Nikolic, Boris ;

Hayward, Alison ;

Wood, Lowell ;

Eckhoff, Philip A. ;

Nowak, Martin A. ;

Langer, Robert ;

Traverso, Giovanni .

NATURE COMMUNICATIONS, 2018, 9

[10] CNS Neurotoxicity of Antiretrovirals [J].

Lanman, Tyler ;

Letendre, Scott ;

Ma, Qing ;

Bang, Anne ;

Ellis, Ronald .

JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2021, 16 (01) :130-143

← 1 2 3 →